LENZ Therapeutics (LENZ)
NASDAQ:LENZ
Want to see LENZ full AI Analyst Report?
LENZ Therapeutics (LENZ) Ownership Overview
15.24% Insiders
18.43% Mutual Funds
50.72% Other Institutional Investors
7.83% ETFs
7.78% Public Companies and
Individual Investors
The ownership structure of LENZ Therapeutics (LENZ) stock is a mix of institutional, retail, and individual investors. Approximately 76.98% of the company’s stock is owned by Institutional Investors, 15.24% is owned by Insiders, and 7.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 30, 2026 | xxxxxxxxxxxxx | $64275 | |
Mar 30, 2026 | xxxxxxxxxxxxx | $49881 | |
Mar 30, 2026 | xxxxxxxxxxxxx | $251397 | |
Nov 10, 2025 | xxxxxxxxxxxxx | $239190 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $4320630 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,178,823 | Institution | 13.33% | 30,672,561 | |
| 3,612,211 | Institution | 11.52% | 26,513,629 | |
| 2,656,888 | Institution | 8.47% | 19,501,558 | |
| 2,656,888 | Insider | 8.47% | 19,501,558 | |
| 1,907,874 | Institution | 6.08% | 14,003,795 | |
| 1,389,510 | Insider | 4.43% | 10,199,003 | |
| 1,169,156 | Institution | 3.73% | 8,581,605 | |
| 1,018,041 | Institution | 3.25% | 7,472,421 | |
| 1,001,685 | Institution | 3.19% | 7,352,368 | |
| 631,099 | Insider | 2.01% | 4,632,267 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,907,874 | Institution | 6.08% | 14,003,795 | |
| 1,001,685 | Institution | 3.19% | 7,352,368 | |
| 518,908 | Institution | 1.65% | 3,808,785 | |
| 374,200 | Institution | 1.19% | 2,746,628 | |
| 365,000 | Institution | 1.16% | 2,679,100 | |
| 265,588 | Institution | 0.85% | 1,949,416 | |
| 224,690 | Institution | 0.72% | 1,649,225 | |
| 172,003 | Institution | 0.55% | 1,262,502 | |
| 170,941 | Institution | 0.55% | 1,254,707 | |
| 169,261 | Institution | 0.54% | 1,242,376 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 762,154 | Institution | 2.43% | 6,973,709 | |
| 456,901 | Institution | 1.46% | 3,614,087 | |
| 253,998 | Institution | 0.81% | 2,324,082 | |
| 201,811 | Institution | 0.64% | 1,596,325 | |
| 163,638 | Institution | 0.52% | 1,294,377 | |
| 105,510 | Institution | 0.34% | 1,054,045 | |
| 98,545 | Institution | 0.31% | 901,687 | |
| 65,022 | Institution | 0.21% | 514,324 | |
| 53,646 | Institution | 0.17% | 424,340 | |
| 51,366 | Institution | 0.16% | 406,305 |
FAQ
Who Owns LENZ Therapeutics (LENZ)?
According to the latest TipRanks data, approximately 50.72% of the company's stock is held by institutional investors, 15.24% is held by insiders, and 7.78% is held by retail investors.
What percentage of LENZ Therapeutics (LENZ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.72% of LENZ Therapeutics (LENZ) stock is held by institutional investors.
What percentage of LENZ Therapeutics (LENZ) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.78% of LENZ Therapeutics (LENZ) stock is held by retail investors.
Who owns the most shares of LENZ Therapeutics (LENZ)?
Peter Kolchinsky owns the most shares of LENZ Therapeutics (LENZ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.